About Sterile India Private Limited
Data last updated:
Sterile India Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 05 June 1989 and has been in existence for over 37 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1989PTC036517. Its GSTIN is 07AAACU5331M3Z5 (Delhi). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹31.45 Cr and a paid-up capital of ₹11.03 Cr. It was formerly known as Uniways Laboratores Pvt Ltd and Uniways Laboratories Private Limited. It is led by directors including Prem Chand Goel and Rajni Goel.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Unit No 501 5th Floor Aggarwal Corporate Heights Plot No. A – 7 Netaji Subhash Place Pita, Mpura, New Delhi, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹791.14 Cr, a decline of 13% compared to the previous year. For the same year it recorded a net profit of ₹73.57 Cr (net margin 9.3%) and EBITDA of ₹110.09 Cr (EBITDA margin 13.9%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 9% over five years.
The company has about 256 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sterile India. As per MCA filings, the company has open charges of ₹163.48 Cr and satisfied charges of ₹78.58 Cr on record. Court records list 34 cases involving the company, including 24 filed by the company and 10 filed against it; 13 cases are pending. The company has 13 deals on record (9 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹64.06 Cr; the latest was in March 2025. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Shilpa Pharma Lifesciences Limited with revenue of ₹849.95 Cr. The company has 13 MSME Form 1 returns on record between 2019 and 2024, listing 600 overdue payments to 89 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sterileindia.com.
Company details
Name history
Sterile India has undergone 2 name changes throughout its history. The company was previously known as Uniways Laboratores Pvt Ltd, and Uniways Laboratories Private Limited. The current legal name is Sterile India Private Limited.
| Company Name | Status |
|---|---|
| Sterile India Private Limited | Current |
| Uniways Laboratores Pvt Ltd | Previous |
| Uniways Laboratories Private Limited | Previous |
Contact details
Sterile India Private Limited's registered office is in New Delhi, Delhi. Its website is sterileindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit No 501 5th Floor Aggarwal Corporate Heights Plot No. A – 7 Netaji Subhash Place Pita, Mpura, New Delhi, Delhi, India – 110034
- IndustryPharma, API Manufacturers
To see the full contact details of Sterile India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Sterile India operates one associated brand: Sterile India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality sterile active pharmaceutical ingredients for the healthcare industry. | sterileindia.com |
Business activity
The main business activity of Sterile India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sterile India Private Limited, buy the company report.
Financials of Sterile India Private Limited
FY 2024 filings availableSterile India Private Limited reported revenue of ₹791.14 Cr (down 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 13% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹110.09 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹73.57 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.9% | ||||
| Net Profit Margin | 9.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sterile India Private Limited, buy the company report.
Board of directors of Sterile India Private Limited
Sterile India has 3 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prem Chand Goel Also directs: Vibs Infrabuild LLP, Nice Seattle Real Estate LLP, Dreamachieve Infratech LLP and 4 more | Director | 31 Oct 2009 | 17 Years 0 Months | Current |
| Rajni Goel | Director | 10 Jun 2013 | 13 Years 4 Months | Current |
| Sanjeev Goel | Director | 04 Jun 2011 | 15 Years 4 Months | Current |
Peer comparison
Sterile India Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shilpa Pharma Lifesciences Limited | ₹849.95 Cr (FY 2025) | -1.0% | Raichur, Karnataka, India | |||
| India Pesticides Limited. | ₹843.44 Cr (FY 2025) | 21.0% | Uttar Pradesh, India | |||
| Virupaksha Organics Limited | ₹816.52 Cr (FY 2025) | 6.0% | Hyderabad, Telangana, India | |||
| Symed Labs Limited | ₹791.92 Cr (FY 2025) | 6.0% | Hyderabad, Telangana, India | |||
| Sterile India Private Limitedthis company | ₹791.14 Cr (FY 2025) | ₹73.57 Cr | 9.3% | -13.0% | 256 | New Delhi, Delhi, India |
| SMS Pharmaceuticals Limited | ₹788.97 Cr (FY 2025) | 11.0% | Hyderabad, Telangana, India | |||
| Symbiotec Pharmalab Limited | ₹755.98 Cr (FY 2025) | 5.0% | Mhow, Madhya Pradesh, India | |||
| Tagoor Laboratories Private Limited | ₹719.28 Cr (FY 2022) | 55.0% | Andhra Pradesh, India | |||
| Optimus Drugs Private Limited | ₹713.55 Cr (FY 2024) | -41.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Sterile India Private Limited, buy the company report.
Auditor
Sterile India Private Limited is audited by P N A M & Co for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P N A M & Co | FY 2024 | 001092N |
Shareholding
The shareholding of Sterile India Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sterile India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Aug 2018 | 100202510 | Others | ₹40 Cr | Open | |
| 01 Dec 2015 | 10609839 | Citi Bank N.A. | ₹75 Cr | Open | |
| 25 Nov 2011 | 10319944 | Hdfc Bank Limited | ₹48.48 Cr | Open | |
| 11 Dec 2019 | 100324362 | Hdfc Bank Limited | ₹78.48 Cr | Satisfied | |
| 20 Feb 2016 | 100033110 | Others | ₹10 Lakh | Satisfied |
To see the full charge records of Sterile India Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Sterile India Private Limited has 13 deals on record (9 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹64.06 Cr; the latest was in March 2025.
Deals on record (5 of 13)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2025 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Prem Chand Goel HUF, 3 individuals |
| Mar 2024 | Secondary share transfer | Undisclosed | Seller: Calendula Dealcom Private Limited , Versatile Vinimay Private Limited , 2 individuals |
| Apr 2015 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Mahima Lifesciences Private Limited , 2 individuals |
| Mar 2014 | Funding round | ₹8.1 Cr | Investors: Bluestar Dealers Private Limited , Sanjeev Goel HUF, 2 individuals |
| Mar 2013 | Funding round | ₹25.45 Cr | Investors: Calendula Dealcom Private Limited , Bluestar Dealers Private Limited , Versatile Vinimay Private Limited |
To see the full deal history of Sterile India Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Sterile India Private Limited has 34 court cases on record: 24 filed by Sterile India, 10 filed against it. 13 cases are pending and 21 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 22 | 8 | 9 |
| High courts | 10 | 1 | 4 |
| Supreme Court | 1 | 1 | 0 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 34)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against Aristo Raw Pharma Pvt Ltd | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against Blessings Healthcare Pvt Ltd | Pending |
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed by the company against Ja Sterile Private Limited & Anr. | Pending |
| High Court of Delhi | Court case (RFA(COMM)) | Filed by the company against M/S Oscar Remedies Pvt Ltd | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against Ja Sterile Private Limited & Ors. | Pending |
To see the full case history of Sterile India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Sterile India Private Limited has 13 MSME Form 1 returns on record between 2019 and 2024, listing 600 overdue payments to 89 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 89)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Chempharm Industries India Private Limited | |||
| an individual supplier | |||
| Contec Airflow Projects Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Sterile India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Sterile India Private Limited has a workforce of 256 employees on its EPFO records as of Mar 27, 2025, across 1 active EPFO establishment.
GST
Sterile India has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACU5331M3Z5 | Delhi | Active | 02 Sep 2019 |
| 06AAACU5331M1Z9 | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sterile India Private Limited, buy the company report.
Recent activity
Sterile India Private Limited has 9 board changes on record since 2007: 3 appointments and 6 cessations. The latest: Aarti Bhasin ceased to be Company Secretary on 09 Sep 2017.
11 earlier events are in the company report.
Frequently asked questions
Sterile India is an active private limited company based in New Delhi, Delhi, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 05 June 1989 (37+ years old) and is registered under CIN U74899DL1989PTC036517.
Sterile India has 3 current directors:
- Prem Chand Goel - Director
- Rajni Goel - Director
- Sanjeev Goel - Director
The latest financial statements of Sterile India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Sterile India is 07AAACU5331M3Z5, registered in Delhi. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 06AAACU5331M1Z9 (Haryana).
The CIN (Corporate Identification Number) of Sterile India is U74899DL1989PTC036517. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sterile India has 34 court cases on record: 24 filed by the company and 10 filed against it. 13 are pending. Most are in the district courts.
Sterile India was incorporated on 05 June 1989, making it 37+ years old. It is registered with the Registrar of Companies, Delhi.
Sterile India has 13 deals on record (9 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹64.06 Cr; the latest was in March 2025.
The peers of Sterile India by revenue are Shilpa Pharma Lifesciences Limited, India Pesticides Limited, Virupaksha Organics Limited, Symed Labs Limited, SMS Pharmaceuticals Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Aarti Bhasin ceased to be Company Secretary on 09 Sep 2017. Rajni Goel was appointed as Director on 10 Jun 2013. Pavel Garg ceased to be Director on 22 Sep 2012. Sterile India has 9 board changes on record in total.
Sterile India has 13 MSME Form 1 returns on record between 2019 and 2024, listing 600 overdue payments to 89 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Sterile India can be reached through the website sterileindia.com. Its registered office is in New Delhi, Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
